Adherence to combination antiretroviral therapy has a strong impact on virologic response
and emergence ofviral resistance. However, monitoring adherence in the clinic is difficult …

Clinical effectiveness of the new highly active antiretroviral therapies depends in large part
on patients' ability to adhere to demanding medication regimens because the suboptimal …

Poor adherence to antiretroviral treatment regimens has serious consequences for human
immunodeficiency virus—infected patients, including failure to prevent viral replication and …

In both clinical trials and clinical practice, nonadherence to medications is widespread
among patients with chronic diseases. The shift to combination therapies for treating human …

HIV-related morbidity and mortality have been dramatically improved in populations treated
with combination antiretroviral therapy. Although it is widely recognized that adherence to …

Adherence to antiretroviral regimens by HIV-infected patients is necessary to prolong viral
suppression and forestall viral resistance. This review covers the major advances made in …

Highly active antiretroviral therapy (HAART) has altered dramatically the natural history of
HIV disease. Restoration and prolonged maintenance of good health, reduced morbidity …

Background: Optimal adherence to highly active antiretroviral therapy (HAART) is necessary
to achieve the best and the most durable benefit. Many factors may influence compliance to …

The use of highly active antiretroviral therapy (HAART) has decreased morbidity and
mortality for people living with HIV/AIDS, but adherence to HAART is a critical factor in …

Treatment adherence is generally regarded as an important factor in achieving optimal
outcomes across many disease states; in the treatment of HIV, poor adherence to treatment …